Spora Health is a virtual-first primary care network founded in 2019 in San Francisco that provides membership-based telemedicine services tailored to people of color. Its clinical offering covers common ailments including allergies, cold and flu, common infections, digestive, musculoskeletal, reproductive, and skin conditions such as wounds, burns, rashes, acne and eczema. The company uses machine learning to predict patient risk profiles and to screen for chronic conditions such as pre-diabetes, hypertension and emphysema. Spora’s services are available in Pennsylvania, Virginia, Florida and Tennessee. The company plans to use new funding to accelerate hiring, product development and marketing to expand its U.S. footprint. It also appointed Louis Capponi, MD, as chief medical officer to oversee clinical development and regulatory initiatives. Spora Health is a primary care provider focused on Black people and people of color, offering telemedicine-based access to doctors, nurse practitioners, nutritionists and other clinicians. Patients subscribe to a $9.99-per-month membership, pay their normal insurance co-pay on the first visit, or a one-time $99 fee if uninsured. The company uses machine learning-driven technology to predict risk profiles and screen for chronic conditions such as pre-diabetes, hypertension and emphysema. Spora launched for patients in Virginia, Tennessee, Pennsylvania and Florida and intends to eventually open physical locations after beginning with telemedicine. It operates the Spora Institute to reeducate providers and address implicit bias, and aims to overindex on providers of color while noting a shortage of physicians of color. Founder and CEO Dan Miller positions the service as an affordable, equity-focused analog to models like One Medical, and the company recently closed a $1.2 million seed round.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Aug 2021